Patanjali slams USFDA report on differential labelling by Patanjali Ayurveda

Baba Ramdev's Patanjali Ayurveda has slammed the US health regulator USFDA for its report raising concerns about differential labelling by Patanjali Ayurveda. In a report, USFDA had claimed that labels on two Patanjali products sold in India were found to have additional medicinal & dietary claims compared to the products manufactured for exports.